|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/46 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61K 31/4748 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 31/46 | (2013.01) | ||
| A61K 31/4748 | (2006.01) | ||
| A61K 31/497 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Patento numeris | 3419623 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17707959.7 |
| Europos patento paraiškos padavimo data | 2017-02-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2017/050912 |
| Data | 2017-02-17 |
| (87) | Numeris | WO 2017/145031 |
| Data | 2017-08-31 |
| (30) | Numeris | Data | Šalis |
| 201662298117 P | 2016-02-22 | US | |
| 201662420702 P | 2016-11-11 | US |
| (72) |
LAFFITTE, Bryan , US
BADMAN, Michael , US
CHEN, Jin , US
LINDGREN, Sam , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | METHODS FOR USING FXR AGONISTS |
| METHODS FOR USING FXR AGONISTS |